These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7852169)

  • 1. Microsporum canis vaccine.
    Wenrick CJ
    J Am Vet Med Assoc; 1994 Oct; 205(7):969. PubMed ID: 7852169
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of ringworm (Microsporum canis) with inactivated fungal vaccine (a case report).
    Mosher CL; Langendoen K; Stoddard P
    Vet Med Small Anim Clin; 1977 Aug; 72(8):1343, 1345. PubMed ID: 242883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Organization of the control of microsporosis caused by Microsporum canis in Moscow].
    Ohukhova AS; Arievich AM; Ostapenko NN
    Vestn Dermatol Venerol; 1979 Jul; (7):28-31. PubMed ID: 484009
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigations of a killed dermatophyte cell-wall vaccine against infection with Microsporum canis in cats.
    DeBoer DJ; Moriello KA
    Res Vet Sci; 1995 Sep; 59(2):110-3. PubMed ID: 8525097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunologic effects after inoculation of inactivated and combined live-inactivated dermatophytosis vaccines in cats.
    DeBoer DJ; Moriello KA; Blum JL; Volk LM; Bredahl LK
    Am J Vet Res; 2002 Nov; 63(11):1532-7. PubMed ID: 12428663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental immunity to Microsporum canis and cross reactions with other dermatophytes of veterinary importance.
    Pier AC; Hodges AB; Lauze JM; Raisbeck M
    J Med Vet Mycol; 1995; 33(2):93-7. PubMed ID: 7658308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pre-treatment with lufenuron for the prevention of Microsporum canis infection in a feline direct topical challenge model.
    Moriello KA; Deboer DJ; Schenker R; Blum JL; Volk LM
    Vet Dermatol; 2004 Dec; 15(6):357-62. PubMed ID: 15585010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New studies on the characterization of virulence factors in Microsporum canis].
    Mignon B
    Bull Mem Acad R Med Belg; 2005; 160(5-6):270-5. PubMed ID: 16465781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune responses in cats with dermatophytosis.
    Sparkes AH; Stokes CR; Gruffydd-Jones TJ
    Am J Vet Res; 1993 Nov; 54(11):1869-73. PubMed ID: 8291765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence, immunity and treatment of feline dermatophytosis].
    Favrot C; Zaugg N
    Schweiz Arch Tierheilkd; 2005 May; 147(5):205-12. PubMed ID: 15929601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immune responses to Microsporum canis in naturally occurring feline dermatophytosis.
    DeBoer DJ; Moriello KA
    J Med Vet Mycol; 1993; 31(2):121-32. PubMed ID: 8509949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity in guinea-pigs of a crude ribosomal fraction from Microsporum canis.
    Elad D; Segal E
    Vaccine; 1994 Feb; 12(2):134-8. PubMed ID: 8147094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [[Epidemiology, clinic and treatment of dermatomycoses caused by zoophilic dermatophytes] ].
    Seebacher C
    Mycoses; 2000; 43 Suppl 1():4-7. PubMed ID: 11098618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an in vitro, isolated, infected spore testing model for disinfectant testing of Microsporum canis isolates.
    Moriello KA; Deboer DJ; Volk LM; Sparkes A; Robinson A
    Vet Dermatol; 2004 Jun; 15(3):175-80. PubMed ID: 15214954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural focus of microsporosis caused by Microsporum canis Bodin.
    Ditrich O; Otcenásek M; Zampachová I
    Folia Parasitol (Praha); 1980; 27(2):173-82. PubMed ID: 7450609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MICROSPORUM CANIS DERMATOMYCOSIS.
    HODGES DJ; RAO A
    Med J Aust; 1965 Feb; 1(9):305-9. PubMed ID: 14261913
    [No Abstract]   [Full Text] [Related]  

  • 17. [A Microsporum canis epidemic in a Groninger rural area].
    ten Berge-van der Schaaf J; Kruis-de Vries MH
    Ned Tijdschr Geneeskd; 1988 Mar; 132(13):582-3. PubMed ID: 3362226
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of immunogenicity and protective efficacy of Microsporum canis secreted components coupled to monophosphoryl lipid-A adjuvant in a vaccine study using guinea pigs.
    Cambier L; Băguţ ET; Heinen MP; Tabart J; Antoine N; Mignon B
    Vet Microbiol; 2015 Feb; 175(2-4):304-11. PubMed ID: 25532779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immunogenicity and protective efficacy of a Microsporum canis metalloprotease subunit vaccine in guinea pigs.
    Vermout SM; Brouta FD; Descamps FF; Losson BJ; Mignon BR
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):75-80. PubMed ID: 14734190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological pattern and humoral immune response to a crude exo-antigen and purified keratinase of Microsporum canis in symptomatic and asymptomatic infected cats.
    Mignon BR; Coignoul F; Leclipteux T; Focant C; Losson BJ
    Med Mycol; 1999 Feb; 37(1):1-9. PubMed ID: 10200928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.